Anti-Endoglin / CD105 (Angiogenesis Marker) Monoclonal Antibody (Clone: ENG/3269)

CD105/Endoglin is a Type I membrane glycoprotein located on cell surfaces and is part of the TGF-alphabeta receptor complex. This protein has been found on endothelial cells, activated macrophages, fibroblasts, and smooth-muscle cells. Endoglin has a role in the development of the cardiovascular system and in vascular remodeling. Its expression is regulated during heart development. CD105 is highly expressed in endothelial cells during tumor angiogenesis and inflammation, with weak or negative expression in vascular endothelium of normal tissues. Angiogenesis is a promising prognostic marker in a variety of tumors. Endoglin is a more specific and sensitive marker for tumor angiogenesis than CD31 or CD34, as it labels only newly-formed blood vessels and may serve as a prognostic marker for Prostate Adenocarcinoma, and cancers of the lung, stomach, breast, and brain.

Product Specifications

Product Name Alternative

CD105; END; Endoglin; Eng; HHT1; S-endoglin

Gene Name

ENG

Gene ID

2022

UniProt

P17813

Host

Mouse

Reactivity

Human

Immunogen

Recombinant human Endoglin protein fragment (aa74-251) (exact sequence is proprietary)

Clonality

Monoclonal

Clone

ENG/3269

Applications

IHC

Components

200 μg/mL of Ab Purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/mL.

Storage Conditions

Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous.

Applications Notes

Immunohistochemistry (Formalin-fixed) (1-2ug/ml for 30 minutes at RT), (Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95&degC followed by cooling at RT for 20 minutes)